PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA. Rangaprasad.Sarangarajan@BergHealth.com.\', \'Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, 23298, USA.\', \'BERG LLC, 500 Old Connecticut Path, Bldg B, 3r Floor, Framingham, MA, 01701, USA.\', \'Center for Medicines Discovery, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, OX37DQ, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s40615-020-00853-0
?:hasPublicationType
?:journal
  • Journal of racial and ethnic health disparities
is ?:pmid of
?:pmid
?:pmid
  • 32901433
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.464
?:rankingScore_hIndex
  • 8
is ?:relation_isRelatedTo_publication of
?:title
  • Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all